News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OncoSec Medical Inc.l Selected To Present Phase II Data In Poster Highlights Session At 2014 American Society of Clinical Oncology Annual Meeting


4/22/2014 6:48:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OncoSec Medical Inc. (OTCQB: ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present an update of data from their Phase 2 melanoma study at the American Society of Clinical Oncology’s 50th Annual Meeting, taking place May 30-June 3, 2014, at McCormick Place in Chicago, Illinois. Additional details will be made available on or after May 14, 2014, via the ASCO webpage: http://www.asco.org

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES